Sleep duration, lifestyle intervention, and incidence of type 2 diabetes in impaired glucose tolerance: The finnish diabetes prevention study

Diabetes Care

Volumn 32, Issue 11, 2009, Pages 1965-1971

  Tuomilehto, Henri ^a,b   Peltonen, Markku ^c   Partinen, Markku ^d,e   Lavigne, Gilles ^b   Eriksson, Johan G ^c,e,f   Herder, Christian ^g   Aunola, Sirkka ^c   Keinänen Kiukaanniemi, Sirkka ^h   Ilanne Parikka, Pirjo ⁱ   Uusitupa, Matti ^j   Tuomilehto, Jaakko ^e,k   Lindström, Jaana ^c  

^a KUOPIO UNIVERSITY HOSPITAL   (Finland)

^b UNIVERSITÉ DE MONTRÉAL   (Canada)

^c NATIONAL PUBLIC HEALTH INSTITUTE   (Finland)

^d Rinnekoti Foundation Finland   (Finland)

^e UNIVERSITY OF HELSINKI   (Finland)

^f VAASA CENTRAL HOSPITAL   (Finland)

^g HEINRICH HEINE UNIVERSITY   (Germany)

^h UNIVERSITY OF OULU   (Finland)

ⁱ Finnish Diabetes Association   (Finland)

^j UNIVERSITY OF EASTERN FINLAND   (Finland)

^k SOUTH OSTROBOTHNIA CENTRAL HOSPITAL   (Finland)

more..

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; INTERLEUKIN 6;

ADULT; ARTICLE; BODY WEIGHT; CONTROLLED STUDY; DAYTIME SOMNOLENCE; DIETARY INTAKE; DISEASE ASSOCIATION; EXERCISE; FEMALE; FOLLOW UP; HUMAN; IMPAIRED GLUCOSE TOLERANCE; INCIDENCE; INSULIN SENSITIVITY; LIFESTYLE MODIFICATION; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; PATIENT COUNSELING; PHYSICAL ACTIVITY; RISK FACTOR; SLEEP PATTERN; WEIGHT REDUCTION;

BLOOD PRESSURE; C-REACTIVE PROTEIN; DIABETES MELLITUS, TYPE 2; DIETARY FATS; DIETARY FIBER; ENERGY INTAKE; FEMALE; FINLAND; GLUCOSE INTOLERANCE; HUMANS; INCIDENCE; LIFE STYLE; MALE; MIDDLE AGED; MOTOR ACTIVITY; REST; RISK FACTORS; SLEEP; WAIST CIRCUMFERENCE;

EID: 70449358697     PISSN: 01495992     EISSN: 19355548     Source Type: Journal    
DOI: 10.2337/dc08-1980     Document Type: Article

References (23)

1. Kripke DF, Garfinkel L, Wingard DL, Klauber MR, Marler MR. Mortality associated with sleep duration and insomnia. Arch Gen Psychiatry 2002;59:131-136 (Pubitemid 34137380)
2. Yaggi HK, Araujo AB, McKinlay JB. Sleep duration as a risk factor for the development of type 2 diabetes. Diabetes Care 2006;29:657-661 (Pubitemid 44115369)
3. Ayas NT, White DP, Al-Delaimy WK, Manson JE, Stampfer MJ, Speizer FE, Patel S, Hu FB. A prospective study of self-reported sleep duration and incident diabetes in women. Diabetes Care 2003;26:380-384 (Pubitemid 36929059)
4. Tuomilehto H, Peltonen M, Partinen M, Seppä J, Saaristo T, Korpi-Hyövälti E, Oksa H, Saltevo J, Puolijoki H, Vanhala M, Tuomilehto J. Sleep duration is associated with an increased risk for the prevalence of type 2 diabetes in middle-aged women: the FIN-D2D survey. Sleep Med 2008;9:221-227
5. Spiegel K, Leproult R, Van Cauter E. Impact of sleep debt on metabolic and endocrine function. Lancet 1999;354:1435-1439 (Pubitemid 29494756)
6. Young T, Skatrud J, Peppard PE. Risk factors for obstructive sleep apnea in adults. JAMA 2004;291(16):2013-2016 (Pubitemid 38544284)
7. Capuron L, Su S, Miller AH, Bremner JD, Goldberg J, Vogt GJ, Maisano C, Jones L, Murrah NV, Vaccarino V. Depressive symptoms and metabolic syndrome: is inflammation the underlying link. Biol Psychiatry 2008;64:896-900
8. Lindström J, Louheranta A, Mannelin M, Rastas M, Salminen V, Eriksson J, Uusitupa M, Tuomilehto J. The Finnish Diabetes Prevention Study Group: lifestyle intervention and 3-year results on diet and physical activity. Diabetes Care 2003;26:3230-3236 (Pubitemid 37466880)
9. Lindström J, Ilanne-Parikka P, Peltonen M, Aunola S, Eriksson JG, Hemiö K, Hämäläinen H, Härkönen P, Keinänen-Kiukaanniemi S, Laakso M, Louheranta A, Mannelin M, Paturi M, Sundvall J, Valle TT, Uusitupa M, Tuomilehto J. Finnish Diabetes Prevention Study Group. Sustained reduction in the incidence of type 2 diabetes by lifestyle intervention: the follow-up results of the Finnish Diabetes Prevention Study. Lancet 2006;368:1673-1679
10. Lakka TA, Salonen JT. Intra-person variability of various physical activity assessments in the Kuopio Ischaemic Heart Disease Risk Factor Study. Int J Epidemiol 1992;21:467-472
11. World Health Organization. Diabetes Mellitus: Report of a WHO Study Group. Geneva, World Health Org., 1985 (Tech. Rep. Ser., no. 727)
12. Herder C, Peltonen M, Koenig W, Kräft I, Müller-Scholze S, Martin S, Lakka T, Ilanne-Parikka P, Eriksson JG, Hämäläinen H, Keinänen-Kiukaanniemi S, Valle TT, Uusitupa M, Lindström J, Kolb H, Tuomilehto J, for the Finnish Diabetes Prevention Study Group. Systemic immune mediators and lifestyle changes in the prevention of type 2 diabetes: results from the Finnish Diabetes Prevention Study. Diabetes 2006;55:2340-2346
13. Kronholm E, Härmä M, Hublin C, Aro AR, Partonen T. Self-reported sleep duration in Finnish general population. J Sleep Res 2006;15:276-290 (Pubitemid 44215545)
14. Grandner MA, Drummond SPA. Who are long sleepers? Towards an understanding of the mortality relationship. Sleep Med Rev 2007;11:341-360
15. Patel SR, Malhotra A, Gottlieb DJ, White DP, Hu FB. Correlates of long sleep duration. Sleep 2006;29:881-889
16. Ip MS, Lam B, Ng MM, Lam WK, Tsang KW, Lam KS. Obstructive sleep apnea is independently associated with insulin resistance. Am J Respir Crit Care Med 2002;165:670-676 (Pubitemid 34194755)
17. Tuomilehto H, Seppä J, Partinen M, Peltonen M, Gylling H, Tuomilehto J, Vanninen E, Kokkarinen J, Sahlman J, Martikainen T, Randell J, Tukiainen H, Uusitupa M. Weight reduction is a curative treatment for patients with mild obstructive sleep apnea - a prospective, randomized study. Am J Respir Crit Care Med 2009;179:320-327
18. Uusitupa M, Lindi V, Louheranta A, Salopuro T, Lindström J, Tuomilehto J. Long-term improvement in insulin sensitivity by changing lifestyles of people with impaired glucose tolerance: 4-year results from the Finnish Diabetes Prevention Study. Diabetes 2003;52:2532-2538 (Pubitemid 37210542)
19. Schweitzer PK. Drugs that disturb sleep and wakefulness. In Principles and Practice of Sleep Medicine. 4th ed. Kryger M, Roth Thomas, Dement W, Eds. New York, Elsevier, 2005, p. 499-518
20. Vgontzas AN, Papanicolaou DA, Bixler EO, Kales A, Tyson K, Chrousos GP. Elevation of plasma cytokines in disorders of excessive daytime sleepiness: role of sleep disturbance and obesity. J Clin Endocrinol Metab 1997;82:1313-1316 (Pubitemid 27200394)
21. Williams CJ, Hu FB, Patel SR, Mantzoros CS. Sleep duration and snoring in relation to biomarkers of cardiovascular disease risk among women with type 2 diabetes. Diabetes Care 2007;30:1233-1240
22. Herder C, Peltonen M, Koenig W, Sütfels K, Lindström J, Martin S, Ilanne-Parikka P, Eriksson JG, Aunola S, Keinänen-Kiukaanniemi S, Valle TT, Uusitupa M, Kolb H, Tuomilehto J, the Finnish Diabetes Prevention Study Group. Anti-inflammatory effect of lifestyle changes in the Finnish Diabetes Prevention Study. Diabetologia 2009;52:433-442
23. Lockley SW, Skene DJ, Arendt J. Comparison between subjective and actigraphic measurement of sleep and sleep rhythms. J Sleep Res 1999;8:175-183 (Pubitemid 29433608)